Table 3.
Area | Treatment (n = 6) | # GAD-IR Neurons | # Fos-IR Neurons | # Dual GAD/Fos-IR Neurons |
---|---|---|---|---|
Rostral MnPN | Vehicle | 85.7 ± 1.8 | 27.5 ± 2.3 | 14.9 ± 1.2 |
5 nmol ZM | 88.9 ± 3.1 | 24.4 ± 2.4 | 10.4 ± 2.1* | |
25 nmol ZM | 90.7 ± 2.2 | 22.7 ± 2.8 | 8.3 ± 1.3** | |
ANOVA (Holm-Sidak test) | F(2,15) =1.05 P = 0.37 | F(2,15) =0.97 P = 0.40 | F(2,15) =7.79 P < 0.01 | |
Caudal MnPN | Vehicle | 70.1 ± 3.3 | 17.5 ± 2.3 | 8.5 ± 0.8 |
5 nmol ZM | 71.2 ± 3.1 | 16.9 ± 2.0 | 6.1 ± 0.7* | |
25 nmol ZM | 75.2 ± 2.8 | 14.1 ± 1.9 | 5.2 ± 0.2** | |
ANOVA (Holm-Sidak test) | F(2,15) =0.90 P = 0.42 | F(2,15) =0.71 P = 0.50 | F(2,15) =7.00 P < 0.01 | |
Core VLPO | Vehicle | 38.9 ± 2.7 | 7.1 ± 1.2 | 9.5 ± 1.2 |
5 nmol ZM | 40.5 ± 1.9 | 7.1 ± 1.2 | 6.6 ± 0.7* | |
25 nmol ZM | 42.8 ± 2.9 | 4.1 ± 0.9 | 5.8 ± 0.6** | |
ANOVA (Holm-Sidak test) | F(2,15) =0.70 P = 0.51 | F(2,15) =2.35 P = 0.12 | F(2,15) =4.86 P < 0.05 | |
Extended VLPO | Vehicle | 80.3 ± 6.2 | 13.5 ± 2.4 | 18.6 ± 2.7** |
5 nmol ZM | 87.1 ± 2.7 | 13.4 ± 2.4 | 10.9 ± 1.9** | |
25 nmol ZM | 91.5 ± 2.5 | 9.3 ± 1.5 | 9.0 ± 0.5** | |
ANOVA (Holm-Sidak test) | F(2,15) =1.90 P = 0.18 | F(2,15) =1.26 P = 0.31 | F(2,15) =7.19 P < 0.01 |
All values are expressed as means ± SE.
P < 0.05,
P < 0.01 level of significance (Holm-Sidak test).